Stocks Overview

LAST PRICE
159.8600
TODAY'S CHANGE (%)
Trending Down-0.7500 (-0.4670%)

Bid / Lots
158.4000/ 1
Ask / Lots
159.8500/ 2
Open / Previous Close
159.9900 / 160.6100
Day Range
Low 159.4600
High 160.8700
52 Week Range
Low 143.1300
High 168.8500
Volume
8,613,860
above average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Wednesday's close: 160.61
Time	Volume	JNJ
09:32 ET	80242	159.66
09:34 ET	12508	159.98
09:36 ET	12274	160.1
09:38 ET	24157	160.35
09:39 ET	9417	160.14
09:41 ET	3686	160.37
09:43 ET	22042	160.37
09:45 ET	10636	160.285
09:48 ET	22595	160.24
09:50 ET	12738	160.17
09:52 ET	60083	160.455
09:54 ET	20853	160.61
09:56 ET	12872	160.5
09:57 ET	11331	160.25
09:59 ET	42751	160.52
10:01 ET	20957	160.435
10:03 ET	33828	160.805
10:06 ET	20072	160.57
10:08 ET	27175	160.3
10:10 ET	17306	160.25
10:12 ET	15227	160.1975
10:14 ET	10553	160.43
10:15 ET	9205	160.48
10:17 ET	8884	160.33
10:19 ET	6442	160.41
10:21 ET	9617	160.4
10:24 ET	11021	160.3
10:26 ET	9309	160.38
10:28 ET	8727	160.45
10:30 ET	10798	160.34
10:32 ET	23532	160.56
10:33 ET	19162	160.48
10:35 ET	11974	160.53
10:37 ET	8704	160.32
10:39 ET	7894	160.365
10:42 ET	10527	160.17
10:44 ET	7814	160.18
10:46 ET	13556	160.22
10:48 ET	11690	160.24
10:50 ET	16850	160.33
10:51 ET	26172	160.26
10:53 ET	21421	160.375
10:55 ET	21154	160.37
10:57 ET	22472	160.36
11:00 ET	9675	160.39
11:02 ET	28472	160.47
11:04 ET	12596	160.36
11:06 ET	10900	160.285
11:08 ET	28485	160.27
11:09 ET	8216	160.26
11:11 ET	10258	160.31
11:13 ET	15951	160.41
11:15 ET	53809	160.655
11:18 ET	12880	160.73
11:20 ET	6546	160.615
11:22 ET	17054	160.6
11:24 ET	22907	160.64
11:26 ET	5944	160.71
11:27 ET	13464	160.52
11:29 ET	5746	160.39
11:31 ET	6997	160.41
11:33 ET	10527	160.46
11:36 ET	7897	160.42
11:38 ET	12827	160.43
11:40 ET	6585	160.545
11:42 ET	15240	160.55
11:44 ET	4984	160.65
11:45 ET	13025	160.565
11:47 ET	7450	160.5
11:49 ET	9881	160.535
11:51 ET	20214	160.66
11:54 ET	12776	160.64
11:56 ET	4477	160.57
11:58 ET	12805	160.495
12:00 ET	13383	160.52
12:02 ET	12179	160.57
12:03 ET	13849	160.57
12:05 ET	10595	160.525
12:07 ET	11818	160.51
12:09 ET	11294	160.44
12:12 ET	16641	160.43
12:14 ET	17608	160.43
12:16 ET	9006	160.52
12:18 ET	10946	160.37
12:20 ET	9913	160.42
12:21 ET	10684	160.47
12:23 ET	8402	160.53
12:25 ET	8773	160.46
12:27 ET	10692	160.43
12:30 ET	6523	160.465
12:32 ET	7794	160.43
12:34 ET	19180	160.42
12:36 ET	9223	160.29
12:38 ET	12364	160.365
12:39 ET	11910	160.4
12:41 ET	14082	160.39
12:43 ET	28094	160.385
12:45 ET	14734	160.43
12:48 ET	12691	160.38
12:50 ET	6265	160.425
12:52 ET	7088	160.42
12:54 ET	10911	160.425
12:56 ET	7777	160.3845
12:57 ET	10109	160.39
12:59 ET	13227	160.42
01:01 ET	18710	160.41
01:03 ET	28412	160.46
01:06 ET	30262	160.42
01:08 ET	25384	160.36
01:10 ET	13286	160.35
01:12 ET	35778	160.29
01:14 ET	11584	160.3
01:15 ET	14260	160.24
01:17 ET	11091	160.21
01:19 ET	11563	160.29
01:21 ET	13876	160.27
01:24 ET	21828	160.36
01:26 ET	22274	160.4
01:28 ET	10954	160.46
01:30 ET	12829	160.355
01:32 ET	21716	160.39
01:33 ET	7299	160.18
01:35 ET	10784	160.22
01:37 ET	19807	160.18
01:39 ET	27235	160.1601
01:42 ET	10994	160.09
01:44 ET	12232	160.1871
01:46 ET	13602	160.2
01:48 ET	7357	160.15
01:50 ET	8010	160.1702
01:51 ET	8446	160.16
01:53 ET	9377	160.15
01:55 ET	6626	160.19
01:57 ET	8176	160.24
02:00 ET	9177	160.36
02:02 ET	11647	160.34
02:04 ET	11731	160.39
02:06 ET	13205	160.385
02:08 ET	11905	160.39
02:09 ET	11014	160.36
02:11 ET	10453	160.33
02:13 ET	19300	160.32
02:15 ET	20875	160.28
02:18 ET	17547	160.31
02:20 ET	23116	160.385
02:22 ET	21022	160.4183
02:24 ET	13491	160.38
02:26 ET	13890	160.38
02:27 ET	20818	160.37
02:29 ET	23493	160.355
02:31 ET	29210	160.34
02:33 ET	15281	160.335
02:36 ET	30128	160.245
02:38 ET	14427	160.25
02:40 ET	20335	160.245
02:42 ET	10116	160.25
02:44 ET	6981	160.215
02:45 ET	11300	160.34
02:47 ET	11234	160.33
02:49 ET	7241	160.355
02:51 ET	10186	160.17
02:54 ET	17173	160.28
02:56 ET	11371	160.3
02:58 ET	10428	160.33
03:00 ET	17779	160.3861
03:02 ET	20367	160.34
03:03 ET	25924	160.21
03:05 ET	16840	160.24
03:07 ET	11238	160.18
03:09 ET	12383	160.3035
03:12 ET	15582	160.19
03:14 ET	21064	160.15
03:16 ET	7877	160.21
03:18 ET	11471	160.155
03:20 ET	11307	160.22
03:21 ET	17331	160.2
03:23 ET	18187	160.36
03:25 ET	18286	160.35
03:27 ET	13006	160.31
03:30 ET	15393	160.28
03:32 ET	19648	160.25
03:34 ET	36084	160.21
03:36 ET	22296	160.21
03:38 ET	30733	160.2
03:39 ET	42028	160.155
03:41 ET	50102	160.11
03:43 ET	44367	160.105
03:45 ET	514856	160.0755
03:48 ET	230244	160.205
03:50 ET	103851	160.48
03:52 ET	43445	160.55
03:54 ET	29630	160.35
03:56 ET	60783	160.21289
03:57 ET	93384	159.99
03:59 ET	2060678	159.86

Data delayed at least 15 minutes.

Oct 28, 2024
- DJ AbbVie to Acquire Aliada Therapeutics for $1.4 Billion -- Update, from 11:52AM ET on Monday Oct 28, 2024 by Dow Jones
  11:52AM ET on Monday Oct 28, 2024 by Dow Jones
- DJ What the Election Will Mean for CVS, Pfizer, and Other Healthcare Stocks -- Barrons.com, from 9:28AM ET on Monday Oct 28, 2024 by Dow Jones
  9:28AM ET on Monday Oct 28, 2024 by Dow Jones
- TREMFYA(R) (guselkumab) is the first and only IL-23 inhibitor to demonstrate robust results with a fully subcutaneous regimen in both induction and maintenance in Crohn's disease, from 7:30AM ET on Monday Oct 28, 2024 by Dow Jones
  7:30AM ET on Monday Oct 28, 2024 by Dow Jones
- DJ Healthcare Stocks Await Election Result. How a Trump or Harris Presidency Could Move Markets. -- Barrons.com, from 2:30AM ET on Monday Oct 28, 2024 by Dow Jones
  2:30AM ET on Monday Oct 28, 2024 by Dow Jones
Oct 25, 2024
- New SPECTREM study findings reveal TREMFYA(R) (guselkumab) effectively clears overlooked and undertreated plaque psoriasis, from 8:05AM ET on Friday Oct 25, 2024 by Dow Jones
  8:05AM ET on Friday Oct 25, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesJNJ Johnson & Johnson	386.7B	26.3x	-1.47%
United StatesRHHBY Roche Holding AG	258.4B	20.3x	+3.28%
United StatesABBV AbbVie Inc	355.9B	68.2x	-6.05%
United StatesMRK Merck & Co Inc	265.7B	19.0x	-43.23%
United StatesNVS Novartis AG	240.8B	18.9x	-5.59%
United StatesPFE Pfizer Inc	161.6B	38.0x	-7.10%
As of 2024-10-31

Johnson & Johnson, through its subsidiaries, is engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. The Company's primary focus is products related to human health and well-being. It operates through two segments: Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. Products in this segment are distributed directly to retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment includes a broad portfolio of products used in the orthopedic, surgery, interventional solutions, cardiovascular intervention, and vision fields. The MedTech segment also offers a commercially available intravascular lithotripsy (IVL) platform for coronary artery disease (CAD) and peripheral artery disease (PAD).

Contact Information

Headquarters: One Johnson & Johnson PlazaNEW BRUNSWICK, NJ, United States 08933
Phone: 732-524-2455
Fax: 732-214-0332

Executives

Chairman of the Board, Chief Executive Officer: Joaquin Duato
Chief Financial Officer, Executive Vice President: Joseph Wolk
Chief Human Resource Officer: Kristen Mulholland
Executive Vice President, Chief Technology Officer and Risk Officer: Kathryn Wengel
Executive Vice President, Chief Information Officer: James Swanson

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$386.7B
Revenue (TTM)	$87.7B
Shares Outstanding	2.4B
Dividend Yield	3.10%
Annual Dividend Rate	4.9600 USD
Ex-Dividend Date	11-26-24
Pay Date	12-10-24
Beta	0.52
EPS	$6.08
Book Value	$28.57
P/E Ratio	26.3x
Price/Sales (TTM)	4.4
Price/Cash Flow (TTM)	17.5x
Operating Margin	20.10%

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Johnson & Johnson
NYSE:JNJUnited States

Search Criteria

Charts

Recent News

Oct 28, 2024

DJ AbbVie to Acquire Aliada Therapeutics for $1.4 Billion -- Update, from 11:52AM ET on Monday Oct 28, 2024 by Dow Jones

DJ What the Election Will Mean for CVS, Pfizer, and Other Healthcare Stocks -- Barrons.com, from 9:28AM ET on Monday Oct 28, 2024 by Dow Jones

TREMFYA(R) (guselkumab) is the first and only IL-23 inhibitor to demonstrate robust results with a fully subcutaneous regimen in both induction and maintenance in Crohn's disease, from 7:30AM ET on Monday Oct 28, 2024 by Dow Jones

DJ Healthcare Stocks Await Election Result. How a Trump or Harris Presidency Could Move Markets. -- Barrons.com, from 2:30AM ET on Monday Oct 28, 2024 by Dow Jones

Oct 25, 2024

New SPECTREM study findings reveal TREMFYA(R) (guselkumab) effectively clears overlooked and undertreated plaque psoriasis, from 8:05AM ET on Friday Oct 25, 2024 by Dow Jones

Pharmaceuticals - Diversified Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar